MediciNova Rating Lowered to Hold at MLV & Co (MNOV)

By admin | 6 years ago

MediciNova (NASDAQ: MNOV) was downgraded by investment analysts at MLV & Co from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.

Shares of MediciNova opened at 1.5697 on Thursday. MediciNova has a 52 week low of $1.29 and a 52 week high of $3.38. The company’s market cap is $25.4 million.

MediciNova, Inc. is a Japan-based bio-pharmaceutical company. The Company is engaged in the acquisition and development of low molecular pharmaceutical products for diseases for which no effective treatments are available mainly in the United States market.

About the author